Ritholtz Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.9M Buy
22,420
+271
+1% +$277K 0.4% 32
2026
Q1
$20.4M Sell
22,149
-34
-0.2% -$34.5K 0.35% 39
2025
Q4
$23.8M Sell
22,183
-833
-4% -$796K 0.44% 33
2025
Q3
$17.6M Buy
23,016
+877
+4% +$653K 0.34% 36
2025
Q2
$17.3M Buy
22,139
+1,065
+5% +$828K 0.38% 33
2025
Q1
$17.4M Sell
21,074
-124
-0.6% -$103K 0.52% 31
2024
Q4
$16.4M Sell
21,198
-8
-0% -$6.62K 0.48% 33
2024
Q3
$18.8M Sell
21,206
-1,867
-8% -$1.68M 0.57% 25
2024
Q2
$20.9M Sell
23,073
-211
-0.9% -$169K 0.69% 24
2024
Q1
$18.1M Buy
23,284
+202
+0.9% +$144K 0.62% 25
2023
Q4
$13.5M Sell
23,082
-1,564
-6% -$913K 0.52% 28
2023
Q3
$13.2M Buy
24,646
+306
+1% +$158K 0.59% 27
2023
Q2
$11.4M Buy
24,340
+661
+3% +$277K 0.51% 27
2023
Q1
$8.13M Sell
23,679
-1,228
-5% -$414K 0.41% 28
2022
Q4
$9.11M Sell
24,907
-1,783
-7% -$632K 0.51% 29
2022
Q3
$8.63M Buy
26,690
+17,064
+177% +$5.41M 0.46% 26
2022
Q2
$3.12M Buy
9,626
+1,860
+24% +$558K 0.2% 60
2022
Q1
$2.22M Buy
7,766
+2,698
+53% +$694K 0.15% 81
2021
Q4
$1.4M Buy
5,068
+1,009
+25% +$256K 0.09% 115
2021
Q3
$938K Buy
4,059
+284
+8% +$70.1K 0.07% 154
2021
Q2
$866K Buy
3,775
+776
+26% +$156K 0.06% 165
2021
Q1
$560K Sell
2,999
-520
-15% -$102K 0.05% 189
2020
Q4
$594K Buy
3,519
+93
+3% +$13.9K 0.06% 138
2020
Q3
$507K Sell
3,426
-94
-3% -$14.5K 0.06% 131
2020
Q2
$578K Buy
3,520
+1,301
+59% +$200K 0.07% 102
2020
Q1
$308K Buy
+2,219
New +$305K 0.05% 101

Other funds holding LLY

Ritholtz Wealth Management's LLY Position: Q2 2026 in Review

Ritholtz Wealth Management increased its Eli Lilly (LLY) stake by 1.2% in Q2 2026, buying an estimated $277K and bringing the position to 22,420 shares worth $26.9M. The position accounts for 0.4% of the portfolio, ranked #32.

Ritholtz Wealth Management first reported a position in LLY in Q1 2020 and has held it in 26 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ritholtz Wealth Management held 22,420 shares of Eli Lilly worth $26.9M as of Q2 2026.
  • Ritholtz Wealth Management bought 271 Eli Lilly shares in Q2 2026, an estimated $277K.
  • Eli Lilly made up 0.4% of Ritholtz Wealth Management's portfolio in Q2 2026, its #32 holding.
  • Ritholtz Wealth Management first reported a position in Eli Lilly in Q1 2020 and has held it in 26 quarters since.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.